HLA-DQB1 rs114388793: Genetics and Myositis Risk
The rs114388793 single nucleotide polymorphism is located within the human leukocyte antigen (HLA) complex near the HLA-DQB1 gene on chromosome 6. It resides in high linkage disequilibrium with ancestral immune haplotypes that modulate susceptibility to autoimmune disorders, particularly idiopathic inflammatory myopathies. Carrying the alternative allele represents a moderate statistical risk factor rather than a direct clinical diagnosis.
What each genotype means
Typical inflammatory risk profile
You carry two copies of the common C allele at rs114388793, which is typical for the majority of the population. This genotype is not associated with the increased statistical predisposition to autoimmune inflammatory myopathies linked to the minor ancestral HLA haplotype. Having this baseline profile does not guarantee protection against autoimmune or muscle disorders, as overall health is influenced by many complex genetic and environmental factors.
Carried by roughly 70% to 80% of individuals of European ancestry, and generally more common across most non-European populations.
Moderately elevated autoimmune susceptibility
You carry one copy of the ancestral T allele, which acts as a tag for extended ancestral HLA class II haplotypes. In published genome-wide association studies, this allele correlates with a moderately increased statistical risk of inflammatory myopathies, including polymyositis and dermatomyositis. This reflects a statistical association in population research rather than a diagnosis, and most individuals carrying this variant never develop an autoimmune condition.
Carried by approximately 15% to 25% of individuals of European ancestry; observed at lower frequencies in other global ancestries.
Elevated autoimmune susceptibility
You carry two copies of the ancestral T allele associated with specific ancestral HLA haplotypes in the major histocompatibility complex region. Population genetics studies indicate that homozygosity for this allele is associated with a higher relative statistical predisposition to inflammatory myopathies compared to non-carriers. Because autoimmune conditions involve complex environmental triggers and numerous genetic loci, carrying two copies does not mean you will develop any condition.
Carried by roughly 1% to 3% of individuals of European ancestry, and is comparatively rare in other populations.
Genetic Architecture and Genomic Location
The single nucleotide polymorphism rs114388793 is situated on chromosome 6p21.3, nestled within the dense and highly polymorphic major histocompatibility complex (MHC). Specifically, it maps close to the HLA-DQB1 locus, which encodes a critical component of antigen-presenting immune machinery. The MHC region is widely recognized for exhibiting extensive linkage disequilibrium, meaning clusters of variants tend to be co-inherited across generations as conserved blocks called ancestral haplotypes. Rather than functioning purely as an isolated causative mutation, rs114388793 frequently serves as an informative genomic tag for larger ancestral class II MHC arrangements. Because the surrounding sequence is replete with regulatory elements and variable immune genes, variants like rs114388793 reflect long evolutionary histories of pathogen exposure, balancing selection, and autoimmune susceptibility profiles across human lineages.
Biological Role of the HLA-DQB1 Gene
The HLA-DQB1 gene provides the blueprint for the beta chain of the heterodimeric human leukocyte antigen class II DQ molecule. Together with an alpha chain encoded by HLA-DQA1, it forms a functional surface receptor on specialized antigen-presenting cells such as dendritic cells, B cells, and macrophages. These surface heterodimers capture foreign peptides—such as degraded bacterial or viral proteins—and display them to helper CD4+ T cells to initiate adaptive immune responses. Slight genetic variations in the peptide-binding pocket alter its shape and chemical charge, directly affecting which peptide fragments can be anchored and displayed. When self-peptides are mistakenly accommodated and presented, immune tolerance can break down, leading to the self-directed tissue inflammation characteristic of autoimmune disease.
Association with Inflammatory Myopathies
Genome-wide association studies and immunogenetic surveys have associated rs114388793 and its co-inherited haplotypes with an elevated risk of idiopathic inflammatory myopathies, a spectrum of rare systemic autoimmune conditions that includes dermatomyositis and polymyositis. These conditions manifest as progressive proximal muscle weakness, fatigue, and in some cases, distinctive skin rashes or lung inflammation. The evidence for the association between MHC class II regions and inflammatory myopathies is rated as moderate; while the statistical correlation is well established across large cohorts, no single variant acts deterministically. The presence of the risk allele slightly shifts baseline autoimmune susceptibility, but the vast majority of individuals carrying these ancestral markers never develop clinical myositis due to the critical interplay of environmental triggers, epigenetic regulation, and polygenic background.
Interpreting Results and Clinical Context
Genomic profiling that highlights rs114388793 provides educational context regarding an individual's inherited immunogenetic background, but it cannot be used as a standalone diagnostic tool. Because inflammatory myositis is rare in the general population, an elevated statistical relative risk translates to a very modest absolute risk. A genotype report indicating carrier status does not imply that an individual has muscle damage or that they will ever develop an autoimmune disease. Conversely, an absence of the risk allele does not provide absolute immunity against inflammatory myopathies. Genetic markers in the HLA region should always be evaluated in conjunction with clinical symptoms, physical examinations, and specialized medical testing when relevant.
How common is this variant?
The minor allele occurs at an estimated frequency of approximately 0.09 to 0.18 among individuals of European ancestry, while frequencies remain lower or less well-characterized in other global populations.
Frequently asked questions
Does having the rs114388793 risk allele mean I will develop an autoimmune disease?
No. Carrying the risk allele only indicates a moderately higher statistical probability compared to the average population baseline. Inflammatory myopathies are rare disorders, and the vast majority of people with this genetic marker never develop symptoms.
What is the relationship between rs114388793 and the HLA-DQB1 gene?
The rs114388793 variant is located near the HLA-DQB1 gene and acts as a tag for conserved ancestral haplotypes within the major histocompatibility complex. These haplotypes affect the molecular structure of immune receptors that present peptide fragments to T cells.
Are there medical tests or lifestyle changes I should undertake if I carry this variant?
There are no standard preventive medical interventions or lifestyle modifications prescribed purely on the basis of rs114388793 status. Any evaluation of autoimmune risk should be guided by observable physical symptoms—such as unexplained muscle weakness—in consultation with a physician.
Why does HLA variation differ between ancestries?
The human leukocyte antigen region has evolved under intense selective pressure driven by infectious pathogens across different geographic regions over millennia. As human groups migrated and adapted to distinct microbial environments, specific HLA alleles and ancestral haplotypes became more or less prevalent.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs114388793?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-DQB1
A well-characterized HLA class II regulatory variant strongly and specifically associated with peanut allergy susceptibility.
An intergenic variant in the HLA-DQ region that independently associates with pediatric peanut allergy and food-specific IgE sensitization.
Tag SNP within the major histocompatibility complex associated with HLA 8.1 ancestral haplotype-mediated autoimmune myositis phenotypes.
Class II HLA-DQB1 variant exhibiting robust genome-wide association with IgE-mediated peanut allergy and egg sensitization.
HLA class II region polymorphism exhibiting ancestry-specific risk architecture for peanut allergy.
Risk locus significantly associated with male reproductive anatomical conditions including phimosis and prepuce disorders.